Results 211 to 220 of about 12,201 (250)

Corrigendum to “Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome” [J Hepatol 49 (2008) 107–114] [PDF]

, 2009
Ketevan Pachkoria, M. Isabel Lucena, Esperanza Crespo, Francisco Ruiz‐Cabello, Susana López-Ortega, M. Carmen Fernández‐Santaella, Manuel Romero‐Gómez, A. Madrazo, José Antonio Durán, Ana Malcon de Dios, Y. Borraz, J.M. Navarro, Raúl J. Andrade   +12 more
openalex   +1 more source

486 IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN PATIENTS WITH PRE-EXISTING LIVER DISEASE: AN ANALYSIS OF THE CASES INCLUDED IN THE SPANISH DILI REGISTRY

, 2011
Navarro López, B. García‐Muñoz, Y. Borraz, M. Roble, Agustín Castiella, Marlen Fernandez, R. Pérez-Álvarez, Sonia Blanco, Stefanny Ibeth Viteri Avila, M. Isabel Lucena, Raúl J. Andrade   +10 more
openalex   +1 more source

GENOTYPE POLYMORPHISMS OF NAT2 AND CYP2E1 GENES ASSOCIATED WITH DRUG INDUCED LIVER INJURY (DILI) IN INDONESIAN TUBERCULOSIS PATIENTS

, 2016
Dyah Aryani Perwitasari
openalex   +1 more source

Highlight report: prediction of drug induced liver injury (DILI) with human hepatocytes in vitro [PDF]

Archives of Toxicology, 2017
openaire   +3 more sources

Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative [PDF]

Eric Cohen, Meenal Patwardhan, Ritu Raheja, David Alpers, Raúl J. Andrade, Mark Avigan, James H. Lewis, Don C. Rockey, Francis Chui, Alexandru M. Iacob, Camila C.G. Linardi, Arie Regev, Jesse Shick, M. Isabel Lucena   +13 more
openalex   +1 more source

Tirzepatide-Induced Liver Injury: A Rare Medication Side Effect. [PDF]

ACG Case Rep J
Phox M, Thesing J, Kilgore WR, Alderson J.   +3 more
europepmc   +1 more source

Infliximab-induced autoimmune-like hepatitis in a patient with Crohn's disease: a case report. [PDF]

Future Sci OA
Ayadi S, Merhaben S, Hadj Kacem L, Rammeh S, Mensi A, Belhadj Mabrouk E, Zaimi Y, Mouelhi L.   +7 more
europepmc   +1 more source

TAK-994 mechanistic investigation into drug-induced liver injury. [PDF]

Toxicol Sci
Shinozawa T, Miyamoto K, Baker KS, Faber SC, Flores R, Uetrecht J, von Hehn C, Yukawa T, Tohyama K, Kadali H, von Grotthuss M, Sudo Y, Smith EN, Diogo D, Zhu AZX, Dragan Y, Cebers G, Wagoner MP.   +17 more
europepmc   +1 more source

Management of drug-induced liver injury associated with anti-cancer therapy. [PDF]

Front Physiol
Vincenzi B, Yimin M, Andrade RJ, Morales Castillo M, Akhundova-Unadkat G, Mato JM.   +5 more
europepmc   +1 more source

Insights into medication-induced liver injury: Understanding and management strategies. [PDF]

Toxicol Rep
Tiwari V, Shandily S, Albert J, Mishra V, Dikkatwar M, Singh R, Sah SK, Chand S.   +7 more
europepmc   +1 more source